Interventional endoscopy for benign and malignant bile duct strictures;Interventionelle endoskopie bei benignen und malignen gallengangsstenosen

Zeitschrift fur Gastroenterologie

Volumn 43, Issue 3, 2005, Pages 295-303

  Jakobs, Ralf ^a   Weickert, U ^a   Hartmann, D ^a   Riemann, J F ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Balloon dilation; ERCP; Photodynamic therapy; PTCD; Stenosisbile duct

Indexed keywords

ANTIMITOTIC AGENT; PLASTIC;

BALLOON DILATATION; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE DUCT PROSTHESIS; BIODEGRADABLE IMPLANT; CHOLECYSTECTOMY; CHRONIC PANCREATITIS; ENDOPROSTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; GRAFT OCCLUSION; GRAFT PATENCY; HEALTH CARE COST; HUMAN; INFLAMMATION; LIVER RESECTION; MALIGNANT NEOPLASTIC DISEASE; MATERIAL COATING; OBSTRUCTIVE JAUNDICE; PHOTODYNAMIC THERAPY; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SELF EXPANDING METAL STENT; STENT; STENT OCCLUSION; STENT PATENCY;

BALLOON DILATATION; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLESTASIS, EXTRAHEPATIC; CHOLESTASIS, INTRAHEPATIC; ENDOSCOPY; FOLLOW-UP STUDIES; FORECASTING; HUMANS; JAUNDICE, OBSTRUCTIVE; PANCREATITIS; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS;

EID: 16244395135     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813546     Document Type: Review

References (79)

1. Weickert U, Jakobs R, Riemann JF. Diagnostik des Gallenwegskarzinoms. Internist 2004; 45: 42-48
2. Classen M, Demling L. Endoskopische Sphinkterotomie der Papilla Vateri und Steinextraktion aus dem Ductus Choledochus. Dtsch Med Wschr 1974; 99: 496-497
3. Soehendra N, Reynders-Frederix V. Palliative Gallengangsdrainage, eine neue Methode zur endoskopischen Einführung eines inneren Drains. Dtsch Med Wschr 1979; 104: 206-207
4. Dezirel DJ, Milikan KW, Econoumou SG et al. Complications of laparoscopic cholecystectomy: a national survey of 4292 hospitals and an analysis of 77,604 cases. Am J Surg 1993; 165: 9-14
5. Hasegawa K, Yazumi S, Egawa H et al. Endosopic management of postoperative biliary compliactions in donors for living donor transplantation. Clin Gastroenterol Hepatol 2003; 1: 183-188
6. Jakobs R, Riemann JF. The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer. Gastroenterology Clinics of North America 1999; 28: 783-800
7. Hintze RE, Abou-Rebyeh H, Adler A et al. Endoscopic therapy of ischemia-type biliary lesions in patients following liver transplantation. Z Gastroenterol 1999; 37: 13-20
8. Johnson GK, Geenen JE, Venu RP et al. Endoscopic treatment of biliary strictures in sclerosing cholangitis: a larger series and recommendations for treatment. Gastrointest Endosc 1991; 37: 38-43
9. Escare JJ, Shea Ja, Chen W et al. Outcomes of open cholecystectomy in the elderly: A longitudinal analysis of 21000 cases in the prelaparoscopic era. Surgery 1995; 117: 156-164
10. Chapman WC, Halevy A, Blumgart LH et al. Postcholecystectomy bile duct strictures. Management and outcome in 130 patients. Arch Surg 1995; 130: 597-602
11. Bergman JJ, Burgemeister L, Bruno MJ et al. Long-term follow-up after biliary stent placement for postoperative bile duct stenosis. Gastrointest Endosc 2001; 54: 154-161
12. Costamagna C, Pandolfi M, Mutignani M et al. Long-term results of endoscopic management of postoperative bile duct strictures with increasing number of stents. Gastrointest Endosc 2001; 54: 162-168
13. De Palma GD, Galloro G, Romano G et al. Long-term follow-up after endoscopic biliary stent placement for bile duct strictures from laparoscopic cholecystectomy. Hepatogastroenterology 2003; 50: 1229-1231
14. Maier M, Schilling D, Kohler B et al. Endoskopische Therapie benigner Gallengangsstenosen: eigene Erfahrungen bei 24 Patienten. Chir Gastroenterol 1993; 9: 142-148
15. Draganov P, Hoffman B, Marsh W et al. Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents. Gastrointest Endosc 2002; 55: 680-686
16. Misra S, Melton GB, Geschwind JF et al. Percutaneous management of bile duct strictures and injuries associated with laparoscopic cholecystectomy: a decade of experience. J Am Coll Surg 2004; 198: 218-226
17. Schumacher B, Othman T, Jansen M et al. Long-term follow-up of percutaneous transhepatic therapy (PTT) in patients with definite benign anastomotic strictures after hepaticojejunostomy. Endoscopy 2001; 33: 409-415
18. Born P, Rösch T, Brühl K et al. Long-term results of endoscopic and percutaneous transhepatic treatment of benign biliary strictures. Endoscopy 1999; 31: 725-731
19. Davids H, Tanka AK, Rau EA et al. Benign biliary strictures - surgery or endoscopy. Ann Surg 1993; 217: 237-243
20. Kiehne K, Fölsch UR, Nitsche R. High complication rate of bile duct stents in patients with chronic alcoholic pancreatitis due to noncompliance. Endoscopy 2000; 32: 377-380
21. Barthet M, Bernard JP, Duval JL et al. Biliary stenting in benign biliary stenosis complicationg chronic calcifying pancreatitis. Endoscopy 1994; 26: 569-572
22. Smits ME, Rauws EAJ, van Gulik TM et al. Long-term results of endoscopic stenting and surgical drainage for biliary stricture due to chronic pancreatitis. Br J Surg 1996; 83: 764-768
23. Farnbacher MJ, Rabenstein T, Ell C et al. Is endoscopic drainage of common bile duct stenoses in chronic pancreatitis up-to-date? Am J Gastroenterol 2000; 95: 1466-1471
24. Eickhoff A, Jakobs R, Leonhardt A et al. Endoscopic stenting for common bile duct stenoses in chronic pancreatitis: results and impact on long-term outcome. Eur J Gastroenterol Hepatol 2001; 13: 1161-1167
25. Kahl S, Zimmermann S, Genz I et al. Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol 2003; 98: 2448-2453
26. Pozsar J, Sahin P, Laszlo F et al. Medium-term results of endoscopic treatment of common bile duct strictures in chronic calcifying pancreatitis with increasing numbers of stents. J Clin Gastroenterol 2004; 38: 118-123
27. Deviere J, Cremer M, Baize M et al. Management of common bile duct stricture caused by chronic pancreatitis with metal mesh self expandable stents. Gut 1994; 35: 122-126
28. Kahl S, Zimmermann S, Glasbrenner B et al. Treatment of benign biliary strictures in chronic pancreatitis by self-expandable metal stents. Dig Dis 2002; 20: 199-203
29. van Berkel AM, Cahen DL, van Westerloo DJ et al. Self-expanding metal stents in benign biliary strictures due to chronic pancreatitis. Endoscopy 2004; 36: 381-384
30. Eickhoff A, Jakobs R, Leonhardt A et al. Self-expandable metal mesh stents for common bile duct stenosis: retrospective evaluation of long-term follow-up and clinical outcome of a pilot study. Z Gastroenterol 2003; 41: 649-654
31. Wadhwa RP, Kozarek RA, France RE et al. Use of self-expandable metallic stents in benign GI diseases. Gastrointest Endosc 2003; 58: 207-212
32. Baluyut AR, Sherman S, Lehman GA et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001; 53: 308-312
33. Stiehl A, Rudolph G, Sauer P et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. J Hepatol 1997; 26: 560-566
34. Ahrendt SA, Pitt HA, Kaloo AN et al. Primary sclerosing cholangitis: Resect, dilate, or transplant? Ann Surg 1998; 227: 412-423
35. Ponsioen CY, Lam K, de van Milligen Wit AWN et al. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 2403-2407
36. van den Hazel SJ, Wolfhagen EH, van Buuren HR et al. Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group. Endoscopy 2000; 32: 779-782
37. de van Milligen Wit AWM, van Bracht J, Rauws EAJ et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1996; 44: 293-296
38. Kaya M, Petersen BT, Angulo P et al. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 2001; 96: 1059-1066
39. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002; 56: 835-841
40. Pereira-Lima JC, Jakobs R, Maier M et al. Endoscopic stenting in obstructive jaundice due to liver metastases: Does it have a benefit for the patient? Hepato-Gastroenterol 1996; 43: 944-948
41. Saleh MM, Norregaard P, Jorgensen HL et al. Preoperative endoscopic stent placement before pancreaticoduodenectomy: a meta-analysis of the effect on morbidity and mortality. Gastrointest Endosc 2002; 56: 529-534
42. Smith AC, Dowsett JF, Russell RCG et al. Randomized trial of surgery versus endoscopic stenting in malignant low bile duct obstruction. Lancet 1994; 344: 1655-1660
43. Pereira-Lima JC, Jakobs R, Maier M et al. Endoscopic biliary stenting for the palliation of pancreatic carcinoma: results, survival predictive factors and comparison of 10-French with 11,5-French gauge stents. Am J Gastroenterol 1996; 91: 1-6
44. Wenderoth DF, Ferslev B, Macarri G et al. Leitbakteria of microbial biofilm communities causing occlusion of biliary stents. Environ Microbiol 2003; 5: 859-866
45. Zhang H, Tsang TK, Jack CA et al. Role of bile mucin in bacterial adherence to biliary stents. J Lab Clin Med 2002; 139: 28-34
46. Weickert U, Venzke T, Konig J et al. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy 2001; 33: 786-790
47. van Berkel AM, Huibregtse IL, Bergman JJ et al. A prospective randomized trial of Tannenbaum-type Teflon-coated stents versus polyethylene stents for distal malignant biliary obstruction. Eur J Gastroenterol Hepatol 2004; 16: 213-217
48. England RE, Martin DF, Morris J et al. A prospective randomised multicentre trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-Leung stents in patients with malignant common duct strictures. Gut 2000; 46: 395-400
49. Catalano MF, Geenen JE, Lehman GA et al. "Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture. Gastrointest Endosc 2002; 55: 354-358
50. Tringali A, Mutignani M, Perri V et al. A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy 2003; 35: 992-997
51. Schilling D, Rink G, Arnold JC et al. Prospective, randomized, single-center trial comparing 3 different 10F plastic stents in malignant mid and distal bile duct strictures. Gastrointest Endosc 2003; 58: 54-58
52. Seo DW. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Gastrointest Endosc 2000; 51: 633-635
53. Galandi D, Schwarzer G, Bassler D et al. Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion. Cochrane Data-base Syst Rev 2002; 3: CD003043
54. Knyrim K, Wagner HL, Rausch J et al. A prospective, randomized, controlled trial of metal stents for distal malignant obstruction. Endoscopy 1993; 25: 207-212
55. Lammer J, Hausegger KA, Fluckiger F et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 1996; 201: 167-172
56. Davids PHP, Groen AK, Rauws EAJ et al. Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-1492
57. McDougall NI, Edmunds SE. An audit of metal stent palliation for malignant biliary obstruction. J Gastroenterol Hepatol 2001; 16: 1051-1054
58. Prat F, Chapat O, Ducot B et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998; 47: 1-7
59. Kaassis M, Boyer J, Dumas R et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003; 57: 178-182
60. Menon K, Romagnuolo J, Barkun AN. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion. Am J Gastroenterol 2001; 96: 1435-1440
61. Matsushita M, Takakuwa H, Nishio A et al. Open-biopsy-forceps technique for endoscopic removal of distally migrated and impacted biliary metallic stents. Gastrointest Endosc 2003; 58: 924-927
62. Bueno JT, Gerdes H, Kurtz RC. Endoscopic management of occluded biliary Wallstents: a cancer center experience. Gastrointest Endosc 2003; 58: 879-884
63. Isayama H, Komatsu Y, Tsujino T et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004; 53: 729-734
64. Bezzi M, Zolovkins A, Cantisani V et al. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction. J Vasc Interv Radiol 2002; 13: 581-589
65. Otto G, Romaneehsen B, Bittinger F et al. Preoperative imaging of hilar cholangiocarcinoma: surgical evaluation of standard practises. Z Gastroenterol 2004; 42: 9-14
66. Hirai I, Kimura W, Fuse A et al. Management of unresectable hilar bile duct cancer-preoperative diagnosis, treatment selection, and clinical outcome. Hepatogastroenterology 2003; 50: 614-620
67. Inal M, Akgul E, Aksungur E et al. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 2003; 14: 1409-1416
68. Cheng JL, Bruno MJ, Bergman JJ et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002; 56: 33-39
69. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47: 354-362
70. Lopera JE, Soto JA, Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology 2001; 220: 90-96
71. Freeman ML, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 2003; 58: 41-49
72. Hintze RE, Abou-Rebyeh H, Adler A et al. Magnetic resonance cholangiopancreaticography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001; 53: 40-46
73. De Palma GD, Galloro G, Siciliano S et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001; 53: 547-553
74. Harewood GC, Baron TH. Cost analysis of magnetic resonance cholangiography in the management of inoperable hilar biliary obstruction. Am J Gastroenterol 2002; 97: 1152-1158
75. Zoepf T, Jakobs R, Arnold JC et al. Photodynamic therapy for palliation of nonresectable bile duct cancer - preliminary results with a new diode laser system. Am J Gastroenterol 2001; 96: 2093-2097
76. Dumoulin FL, Gerhardt T, Fuchs S et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003; 57: 860-867
77. Ortner ME, Caca K, Berr F et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003; 125: 1355-1363
78. Ginsberg G, Cope C, Shah J et al. In vivo evaluation of a new bioabsorbable self-expanding biliary stent. Gastrointest Endosc 2003; 58: 777-784
79. Kalinowski M, Alfke H, Kleb B et al. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions. Invest Radiol 2002; 37: 399-404